Literature DB >> 28433109

Pathogenesis of Wilson disease.

Ivo Florin Scheiber1, Radan Brůha2, Petr Dušek3.   

Abstract

Wilson disease is an autosomal-recessive disorder originating from a genetic defect in the copper-transporting ATPase ATP7B that is required for biliary copper secretion and loading of ceruloplasmin with copper. Impaired ATP7B function in Wilson disease results in excessive accumulation of copper in liver, brain, and other tissues. Toxic copper deposits may induce oxidative stress, modify expression of genes, directly inhibit proteins, and impair mitochondrial function, leading to hepatic, neuropsychiatric, renal, musculoskeletal, and other symptoms. Hepatocyte dysfunction initially manifests as steatosis and later may progress to other hepatic phenotypes such as acute liver failure, hepatitis, and fibrosis. In the brain, copper accumulates in astrocytes, leading to impairment of the blood-brain barrier and consequent damage to neurons and oligodendrocytes. Basal ganglia and brainstem are the brain regions with highest susceptibility to copper toxicity and their lesions lead to various combinations of movement and psychiatric disorders. This chapter will give an overview of the essential requirement of copper for biologic processes and the molecular mechanisms employed by cells to maintain their copper levels in a proper range. We will specify the physiologic functions of ATP7B and the consequences of its dysfunction and summarize the current knowledge on the pathogenesis of liver and neuropsychiatric disease. Finally, we will describe the consequences of copper overload in Wilson disease in other tissues.
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATP7B; Wilson disease; copper; liver fibrosis; neurodegeneration

Mesh:

Substances:

Year:  2017        PMID: 28433109     DOI: 10.1016/B978-0-444-63625-6.00005-7

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  14 in total

Review 1.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

Review 2.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

3.  MR Imaging of the Brain in Neurologic Wilson Disease.

Authors:  X-E Yu; S Gao; R-M Yang; Y-Z Han
Journal:  AJNR Am J Neuroradiol       Date:  2019-01       Impact factor: 3.825

Review 4.  A Practical Approach to Early-Onset Parkinsonism.

Authors:  Giulietta M Riboldi; Emanuele Frattini; Edoardo Monfrini; Steven J Frucht; Alessio Di Fonzo
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

5.  Higher Concentration of Plasma Glial Fibrillary Acidic Protein in Wilson Disease Patients with Neurological Manifestations.

Authors:  Jie Lin; Yexiang Zheng; Ying Liu; Yi Lin; Qiqi Wang; Xiao-Hong Lin; Wenli Zhu; Wei-Hong Lin; Ning Wang; Wan-Jin Chen; Ying Fu
Journal:  Mov Disord       Date:  2021-01-27       Impact factor: 10.338

6.  Investigation of Dynamic Thiol/Disulfide Homeostasis and Nitrosative Stress in Patients with Wilson Disease.

Authors:  Emine Melis Yücel; Bugra Tolga Konduk; Ahmet Saracaloglu; Sezgin Barutçu; Seniz Demiryürek; Fatma Kaba; Belma Dogan Güngen; Abdullah Tuncay Demiryürek
Journal:  Turk J Gastroenterol       Date:  2021-09       Impact factor: 1.555

7.  Improving Editing Efficiency for the Sequences with NGH PAM Using xCas9-Derived Base Editors.

Authors:  Xinyi Liu; Guanglei Li; Xueliang Zhou; Yunbo Qiao; Ruixuan Wang; Shaohui Tang; Jianqiao Liu; Lisheng Wang; Xingxu Huang
Journal:  Mol Ther Nucleic Acids       Date:  2019-07-12       Impact factor: 8.886

8.  Dysregulated Choline, Methionine, and Aromatic Amino Acid Metabolism in Patients with Wilson Disease: Exploratory Metabolomic Profiling and Implications for Hepatic and Neurologic Phenotypes.

Authors:  Tagreed A Mazi; Gaurav V Sarode; Anna Czlonkowska; Tomasz Litwin; Kyoungmi Kim; Noreene M Shibata; Valentina Medici
Journal:  Int J Mol Sci       Date:  2019-11-26       Impact factor: 5.923

9.  Wilson disease patient with rare heterozygous mutations in ATP7B accompanied by distinctive nocturnal enuresis: A case report.

Authors:  Shijie Zhang; Liangyong Li; Jiuxiang Wang
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

10.  Characterization of Fibrinogen as a Key Modulator in Patients with Wilson's Diseases with Functional Proteomic Tools.

Authors:  Pei-Wen Wang; Tung-Yi Lin; Yu-Chiang Hung; Wen-Neng Chang; Pei-Ming Yang; Mu-Hong Chen; Chau-Ting Yeh; Tai-Long Pan
Journal:  Int J Mol Sci       Date:  2019-09-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.